Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05356611 · ClinicalTrials.gov registry record · NA

Engage for Late-Life Depression and Comorbid Executive Dysfunction

A NA study of Mild Cognitive Impairment and Executive Dysfunction, sponsored by University of Nevada, Las Vegas.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05356611: Recruiting NA study of Mild Cognitive Impairment and Executive Dysfunction, sponsored by University of Nevada, Las Vegas.

NCT05356611 is a NA study of Mild Cognitive Impairment and Executive Dysfunction that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 20 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05356611, a NA study of Mild Cognitive Impairment and Executive Dysfunction, is actively recruiting participants, sponsored by University of Nevada, Las Vegas.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies. Engage is a behavioral treatment approach that has shown to be effective in treating late life depression. The investigators are testing the feasibility of Engage as a treatment method for late life depression in older adults with cognitive decline. The objective is to corroborate Engage as an alternative late life depression treatment method for a sub-population of older adults with cognitive decline. Cognitive decline poses a unique mental health treatment barrier that is often over looked in younger populations. With a relatively higher prevalence of cognitive decline in older adulthood, it is imperative that a feasible mental health treatment program that can be effective in the presence of cognitive decline.

Conditions Studied

Mild Cognitive Impairment Executive Dysfunction Psychotherapy Depression in Old Age

Interventions

  • BEHAVIORAL Engage

Study Locations (1)

Nevada

  • University of Nevada - Las Vegas

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-09-24
Est. Completion 2025-05
Phase NA
University of Nevada, Las Vegas

52 total trials

What NCT05356611 shows while recruiting

NCT05356611 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which Engage is the first listed.

NCT05356611 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT05356611 about?

NCT05356611 is a clinical study titled "Engage for Late-Life Depression and Comorbid Executive Dysfunction". Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional menta...

What is the current status of trial NCT05356611?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-09-24. Estimated completion is 2025-05.

What conditions does trial NCT05356611 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Executive Dysfunction, Psychotherapy, Depression in Old Age.

What interventions are being tested in trial NCT05356611?

The interventions under investigation include: Engage (BEHAVIORAL).

Who is sponsoring clinical trial NCT05356611?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05356611 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05356611's enrollment target sits among peer trials

20 174th of 205 higher than 24 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05356611

Source: ClinicalTrials.gov NCT05356611, the US trial registry maintained by the National Library of Medicine. NCT05356611 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.